Received: from DU2PEPF00028D01.eurprd03.prod.outlook.com
 (2603:10a6:10:28d:cafe::64) by DU2PR04CA0201.outlook.office365.com
 (2603:10a6:10:28d::26) with Microsoft SMTP Server (version=TLS1_3,
 cipher=TLS_AES_256_GCM_SHA384) id 15.21.451.14 via Frontend Transport; Tue,
 22 Sep 2026 13:12:56 +0000
Received: from DU2PR04CA0201.eurprd04.prod.outlook.com (2603:10a6:10:28d::26)
 by AM9PR02MB6628.eurprd02.prod.outlook.com (2603:10a6:20b:2cf::15) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.428.16; Tue, 22 Sep
 2026 13:12:56 +0000
Received: by mail-lr2-f35.google.com with SMTP id 38308e7fff4ca-3a6287d59b2so5036631fa.2
        for <info@sm.ee>; Tue, 22 Sep 2026 06:12:54 -0700 (PDT)
Received: from mail1.rit.ee (213.184.53.4) by
 DU2PEPF00028D01.mail.protection.outlook.com (10.167.242.185) with Microsoft
 SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.428.7
 via Frontend Transport; Tue, 22 Sep 2026 13:12:55 +0000
Received: from AM9PR02MB6628.eurprd02.prod.outlook.com (2603:10a6:20b:2cf::15)
 by DB9PR02MB7817.eurprd02.prod.outlook.com with HTTPS; Tue, 22 Sep 2026
 13:12:59 +0000
From: "CF Latvija" <cistiskafibroze.lv.info@gmail.com>
To: "Karmen Joller - SOM" <karmen.joller@sm.ee>
Cc: "Info - SOM" <info@sm.ee>,
	"Gea Otsa - SOM" <gea.otsa@sm.ee>
Subject: =?utf-8?Q?LV=5FInvitation_to_the_Opening_of_?=
	=?utf-8?Q?the_VI_International_Conference_?=
	=?utf-8?Q?=E2=80=9CCystic_Fibrosis_in_the_Baltic_C?=
	=?utf-8?Q?ountries_and_Europe=E2=80=9D?=
Date: Tue, 22 Sep 2026 16:12:16 +0300
Keywords: Mall
Message-ID: <CA+7HbLnMK5E_xamtpPwn8wik5XXA9S_EPS5o8X5A6TpEptbPig@mail.gmail.com>
MIME-Version: 1.0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_000_00C5_01DD4B6A.BB543EE0"
X-Mailer: Microsoft Outlook 16.0
Thread-Index: AQLFsVjTUhgDrAAK9lSoEdWqdUNw0g==
Authentication-Results: spf=softfail (sender IP is 213.184.53.4)
 smtp.mailfrom=gmail.com; dkim=pass (signature was verified)
 header.d=gmail.com;dmarc=pass action=none header.from=gmail.com;compauth=pass
 reason=100
X-CSE-ConnectionGUID: Sdzy4ncDTsKXxS8SQx7IUg==
X-CSE-MsgGUID: inHO/ky3TJ6uJI3SqN31IA==
X-ThreatScanner-Verdict: Negative
X-IPAS-Result: =?us-ascii?q?A0GhBwBRfbJqfGPmfUpahBaBBIELgRQEVIRYgSOCLIw2g?=
 =?us-ascii?q?W6BFophgiSJLIZYE4ErPQIPAQEBAQEBAQEeAQEBAiQUBAEBAwEDOAYJhDeOC?=
 =?us-ascii?q?iAHAUsBAgECAQMCAwEBAQEBAQEBAQEBAQoBAQEEAQEBAgEBAgQDAQEBAQIQA?=
 =?us-ascii?q?QEiGQcOEimGTw2MEztxYQIFAzoBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBA?=
 =?us-ascii?q?QEBAQEBAQEBAQEBBQIsPwEhJx0BCBMMAQEJBgEDEhAwBwIjAREBBQE9DgOCa?=
 =?us-ascii?q?oIiAQYQAQM3FMNNgRUFAhaBATuBUgYFAwIBf9lhChkoDXIDgQxcAgcWhi8qX?=
 =?us-ascii?q?YJAHwGBXwECDoN4hBJ6gSoVgRCBFTWCPgeDUASBJGeDLoJqBIIigQyCSAMWA?=
 =?us-ascii?q?ZFQJggHFwMHBwkFBBwGBQUCPwkFAQ8SAwQDBAQBAgsJCgkDAwIOAggDAggGG?=
 =?us-ascii?q?QE/EgQTCg0LBwUfCgIMFAooIhIrCgECAVUlCwEIBgICBAQCBAwCAwYCAgUHA?=
 =?us-ascii?q?hEDBAEBCAICLQMBAwoPCAkIAgsDAhEYDAsHGhcDEAkDHxcIDggRNAgGAxMBG?=
 =?us-ascii?q?gYFBgs3FQUMEQECGwIfBB0RCAMBGwQCAQkDBBYEAhQKIAIDAwYDCgkCBQMZA?=
 =?us-ascii?q?hgEAQICAwIBAggDBwgDDQMEAgMDAwQBAgIBAQECAwEDAwQDAQYCAQMHAgIDA?=
 =?us-ascii?q?wMLAQIDAwUDAwUFAgIFBQMFAgIKAgMDAwIBAwIaCAMGAxIBEAMDBgEDBwMHA?=
 =
	?us-ascii?q?gQDCQIIAwMICAMXAwMFAQICBAMDCAgEAwMEAgIDDAUDAgMDBQMDBwIEAgQDA?=
 =?us-ascii?q?wEFAQIHAgMHAgEYAwIECAcHBQILBAIIBA0JBAIEAgIPBAYDAwcBAQIBBwUGA?=
 =?us-ascii?q?wICEAEICgUGAgICHAMdAQMNBgEJBQIBBQ4HBQICGAMGAgMGBQEDAQoLAQEDC?=
 =?us-ascii?q?gECBAIFAwMBAwIDAgYDAwIFBQUDCQcFDgkBAwMGBQICAwIDAQIIBAYFAwICA?=
 =?us-ascii?q?wUBBAMEAwoDAggDAwgDDAIaAgUDAwMGCQMHBwIDBwMCBQIHBQMDBQMGAQMCA?=
 =?us-ascii?q?QMDCAsVHwMDAQUDAwIBAwIFAwMYAgIEBQMDAwMDCAQCAgEHBgQCAgIBBQUFB?=
 =?us-ascii?q?AUGAgQDCAEBBQMDCg0BAgcMAwwGAwcDAwQEAwIFCgIEAQcNBwkHAwIDCAEBC?=
 =?us-ascii?q?wQBAwMKAwMFAgEBBwUDBgMHAgMDAwUEBQMCCwMHAgIDAwMCKQEBAQMDAwMDB?=
 =?us-ascii?q?AMBAwEDAwcDBQMCEAcBAQoDAgYDBwYDBQMDAgECAwMFEQMGBAUGFwIGEToBC?=
 =?us-ascii?q?AIDAwEUBAQFAgUVAggBAwMFAwMDAwIFAwEFAQEDAwUDAwMDAwMEAQMEAgMHB?=
 =?us-ascii?q?ggBAQECCAMDAgUDAwMEAwMCAQ0EAgUDBgICBAIEAQcDAQICAQMDAwMBAgQEA?=
 =?us-ascii?q?gcEBQINAwQCAwMFAgMCAwsGAhAEAgMDAwMDEgkIEz0BCwcyBAYwARUUBSkhX?=
 =?us-ascii?q?49sH4FvgisBExw3H2MMSY1KmBWhFQeEIYQdkGaFU4cgM4QEjRSZV
	S6YWqM+M?=
 =?us-ascii?q?CSFIDUSgVsBgWxNIwd6gjYJRwMZD45gg0SBAYJuyC12PQEBAgUCBwIKAQEDC?=
 =?us-ascii?q?QKBVBSQNGthAQE?=
X-Talos-CUID: 9a23:DkiccWwefp6YkObSpj1lBgUvFtI0LnvW4EvLAH+oMjZSca3KaGKfrfY=
X-Talos-MUID: 9a23:5laJvQU5GajReGLq/D7qpBYlN9Yz34bwFWIsyq4fnZLdFAUlbg==
X-IronPort-Anti-Spam-Filtered: true
X-IronPort-AV: E=Sophos;i="6.27,116,1787000400"; 
   d="scan'208,217";a="80729833"
X-Amp-Result: SKIPPED(no attachment in message)
X-Amp-File-Uploaded: False
X-MS-Exchange-Organization-ExpirationStartTime: 22 Sep 2026 13:12:56.0605
 (UTC)
X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit
X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000
X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit
X-MS-Exchange-Organization-Network-Message-Id: 59074895-282a-4ac6-b9ca-08df18ab3790
X-EOPAttributedMessage: 0
X-EOPTenantAttributedMessage: 8fe098d2-428d-4bd4-9803-7195fe96f0e2:0
X-MS-Exchange-Organization-MessageDirectionality: Incoming
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic: DU2PEPF00028D01:EE_|AM9PR02MB6628:EE_|DB9PR02MB7817:EE_
X-MS-Exchange-Organization-AuthSource: DU2PEPF00028D01.eurprd03.prod.outlook.com
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-Office365-Filtering-Correlation-Id: 59074895-282a-4ac6-b9ca-08df18ab3790
X-MS-Exchange-AtpMessageProperties: SA|SL
X-DisclaimerOO: 1
X-MS-Exchange-Organization-SCL: -1
X-Microsoft-Antispam: BCL:0;ARA:13230040|704162211799003|260918224100599003|260918215300599003|7093399015|82310400026|13003099007|19002099009|5023799004|11063799006|10067099003|5063699009|56012099006|18002099003|16102099003|55112099003|8096899003;
X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:en;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(704162211799003)(260918224100599003)(260918215300599003)(7093399015)(82310400026)(13003099007)(19002099009)(5023799004)(11063799006)(10067099003)(5063699009)(56012099006)(18002099003)(16102099003)(55112099003)(8096899003);DIR:INB;
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 22 Sep 2026 13:12:55.8925
 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: 59074895-282a-4ac6-b9ca-08df18ab3790
X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2
X-MS-Exchange-CrossTenant-AuthSource: DU2PEPF00028D01.eurprd03.prod.outlook.com
X-MS-Exchange-CrossTenant-AuthAs: Anonymous
X-MS-Exchange-CrossTenant-FromEntityHeader: Internet
X-MS-Exchange-Transport-CrossTenantHeadersStamped: AM9PR02MB6628
X-MS-Exchange-Transport-EndToEndLatency: 00:00:03.4642939
X-MS-Exchange-Processed-By-BccFoldering: 15.21.0428.008
X-MS-Exchange-ExternalInOutlookResult: NotEnabled
X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710232)(4717077)(4999285)(920097)(930201)(20251009189)(140003);
X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?rAlvhQ9JJmF+YLcp7f+nVr2xkqcf3KgMD8+HjCObu9W15Mvgk+F8INLwK3ja?=
 =?us-ascii?Q?zzSFLINMXrZAFT5D5W+z53HgaZEP1GaX1V23u7sK0tU16txe0h/lWvjKFpWG?=
 =?us-ascii?Q?r9MkABTecNPbFR6sVWiNJH/JU7SVV7taGeANrzt5g0omyTUo1lSiRHPu9AzA?=
 =?us-ascii?Q?8JlRcnud0yn8gN8snEYgDdQX7ANjQQqGkaSdIIPk3xbI/ED4GmP8uZHF5UGQ?=
 =?us-ascii?Q?QY9BxoU5bFkF2TsQ4wVtTHHGk4/Pb4/0K4D4nD3ei73Beyfz5NW7YhH9xgHc?=
 =?us-ascii?Q?XVJGRqfWmhdcTb/udEv5zECQaR8D5NqYOn5c51g61/ooX39xtplZUSIoLR9W?=
 =?us-ascii?Q?UkkbTLvKfgzIckzRR1/4FZ3PGgyVb/VYrEdyvPATk3BF4zkz1o53IC4z8f9g?=
 =?us-ascii?Q?zVyyw+j6JiXtSVLtDlWzJ9M6J0G3spG5KseHlKm0sN+ArvRa3gOQD1SS/b3g?=
 =?us-ascii?Q?IkUHEhhq2Nk2EME1RjNM8aGyMNltxxYBSh/xyKvC8zjaBFERuTaQTIJSoLdX?=
 =?us-ascii?Q?YPN3PTl3KQmY1tYEUWXPA7dJSCgqCxyokySE9TKHVONlaHHCoPu8D9zpMNsr?=
 =?us-ascii?Q?K727SgRjqYveUkWtNg1gqkuIuhvj6nfhLIF+e17+r51jMHralz67cNHba8yK?=
 =?us-ascii?Q?3RoXce/bXt8ZqvHuqErItQuSiN2XoqBIgm1765L14SCfQw6Qso6zwRprsI9u?=
 =?us-ascii?Q?SEjHEvEJF3eLtgZn15W7NisGxwzK8YktJADGoTXJj33Hlqqc1Uf
	x0LV0eeRd?=
 =?us-ascii?Q?q5/aZNwSyKb6zSstUYkaNBVgFKXuGyG4dwyQo6s06Tg+l052jOoIo6MAWtki?=
 =?us-ascii?Q?xGvbpDntlv6Pt+2ag1m1Zm2tqqr5w/BtoSM6A1bmEnY1tmfAVNI2/7ZG6p5P?=
 =?us-ascii?Q?wacLZsD5Oush/tzLErQ7S0F+uDGaP1KwVDfS5HRMAhjcr0YPcTT/vyewtc9Y?=
 =?us-ascii?Q?tGMu/JHdO2nO4MJ43HJjEie8sn82EsXZ9qKsyaeedRvm9ZBr2JMepI/D18iT?=
 =?us-ascii?Q?YB/ANkeGnjocfYZfBRCaOWYp4Lbt8uLka8WK/qQDJ42dl29icDZ+qeI8Xhtj?=
 =?us-ascii?Q?PmXaS5vQVqmdEsJzr4h0hwMTl3TtLLZOYfOdMfHTtJMtCXbomJcl1u2A0hbl?=
 =?us-ascii?Q?lf/YT90RlT0BopIXH2VQ+8HWedzXbkLjhmrnQXjL/J5tO77XaefH8rKkmXdu?=
 =?us-ascii?Q?D5VTOiT5kZdqCY1DQ7o/ggG4PFFkr9gmIcP41qji1o73dLvnbzyXGCrcdTNB?=
 =?us-ascii?Q?C+fZGaptcP5BwkWrqm8VyXfnvPCrWU3B4oHwYBkm97ySN1TU/652x1yd24Bq?=
 =?us-ascii?Q?Hif6kZh+mh5NCplZRiz0mOGz6qUc67Wp+yJgYI92Srh2TN9R9K1WD2YydCiE?=
 =?us-ascii?Q?haYxdSZ7yVSSFLPbu2nI2w2UJDHxutPu8I5UpvALVCewKkBHcGJkACa1QJ16?=
 =?us-ascii?Q?iZwhbflu9zTED0vi+N5xtTbIiAofUVHMEadSEn6uX4VMlgozPbqUBmWoueI+?=
 =?us-ascii?Q?ErEzBktBddzAQ86CGG/qmLAdwzCugCcqz0o5X
	zzK2bS+mgYGkfHY9guef41M?=
 =?us-ascii?Q?M6Qb6CVqXFff9TBKFSpNNqWOG1odXdK7qyGqVG4qQHNFZLg6Fuvm3Hp3/5I1?=
 =?us-ascii?Q?Je2A5yA4DBRi3eMiCtP1pkhE2mqbNGP+QjROjEnNqIrNouDoHJpWZzDWHXJA?=
 =?us-ascii?Q?Nc83xi5pkf87/Q9+q1FLYioUEwqyJgxPzQQBuqTlJtJB66mPMs9hqt5jVAr8?=
 =?us-ascii?Q?/F+Pqn/gMSeLYNjMWB7yrLJ3Xl5aXWkWwkflqzryblqD7sdAlxFRGnGGYAn1?=
 =?us-ascii?Q?M4ySFl8krR3etDVwkv9zM4MnE/6PoLmuohgV+uGjGtzrzs2qfi/pr289l8Z5?=
 =?us-ascii?Q?JmPDyYB9lh9Xhwh9onWTUGk9qeWLU30A2OQPpMpzK5esr9+XnhC1wAgHWbl/?=
 =?us-ascii?Q?7gwJF6THkHShAaSfbaSSQ5Bo9yoAeNOBUgcY02NqNX4VsjD3WDzfHqarNIzP?=
 =?us-ascii?Q?Gs2lG8lgGzioa8djMw2yKcKIXDRKcrg8YffX6v2nRlQqN0TZA4eDAXzHnuEt?=
 =?us-ascii?Q?w6GPw8OAFwymoeR2zT/w9fGmBHFaOVhrSfLXl4g3RnBY7qZSEeemGRIrWTTn?=
 =?us-ascii?Q?bt2A1hUOjKmhD8P4MhhEpLU+35V+6eweRSbqwTD4dhd4pVM4ZYRuxZeX1Awo?=
 =?us-ascii?Q?mgBikMvKIxHbJ4EEdpr8bq+Rr2C8jieBcAmXFKX9qYJ1y0aCMV3Uq9xlZuxB?=
 =?us-ascii?Q?eE6UmWoqZxOA4VYuChoJEqtcD2Y4FUFXhDJcXSTwsP4OuvSjvZfq64fPJWiQ?=
 =?us-ascii?Q?wsaUs+ZLiYXhVzQAW/LM4uk
	fDjmGHT7O+vDYSxtV+mm7dduvf3rnDFcgwZSj?=
 =?us-ascii?Q?J6WzfBk3pGjTMqbt+yQ0pYaLhU3ZNVTX+66qsmJN5UlouP5XzPjPnId8yLCK?=
 =?us-ascii?Q?ZWHGOvYf0YUe2K424gqYatqUfuClrptuugoYxKrvxtTy2zMdHf15WcO/Ufcu?=
 =?us-ascii?Q?nhq+dBYvBubYXYE4YHW6RKYrBLCZ5QZpWmd+3g9cOxoiy0iIv1cMQCC77PRf?=
 =?us-ascii?Q?nwEg1h/XR6cKSl8ccB2QZgUeJ09jGVpEGG+a4Q0Ez4DHv+8gdu9eEcF+yV6Y?=
 =?us-ascii?Q?TwtHhZk2gfA+VhNPQ4syLcp2b2nNqkPw+bx5GVWWAWEUmpgxV3vd6zFOOR0G?=
 =?us-ascii?Q?+bCumypJiUm+FFKZndaWyOtyv7rBBeVjKYxzBtOwscOdG+rZs5QxTq8hRCQJ?=
 =?us-ascii?Q?qQnUYCY2vA=3D=3D?=
Content-Language: en-us
x-ms-exchange-organization-originalclientipaddress: 213.184.53.4
x-ms-exchange-organization-originalserveripaddress: 10.167.242.185
received-spf: None (mail1.rit.ee: no sender authenticity  information available from domain of  postmaster@mail-lr2-f35.google.com) identity=helo;  client-ip=74.125.230.99; receiver=mail1.rit.ee;  envelope-from="cistiskafibroze.lv.info@gmail.com";  x-sender="postmaster@mail-lr2-f35.google.com";  x-conformance=spf_only
dkim-signature: v=1; a=rsa-sha256; c=relaxed/relaxed;        d=gmail.com; s=20251104; t=1790082773; x=1790687573; darn=sm.ee;        h=content-type:cc:to:subject:message-id:date:from:mime-version:from         :to:cc:subject:date:message-id:reply-to:content-type;        bh=nCgFNcVZDZx5AYqGIhxQ65IP19KCUi03ox9yYl50gqk=;        b=ejU8D72BsB3ycmHNZqgpUICnvqWd12zVGbjA9PlDt2q2dSMzbZLoN33h94d5fSQzvO         qT45RxMiNmrdmyk23W6GdbL5wMoSUZ+P701npiPXGZhTkS4HsbVQ5rJ8/WY0jXfSgErP         6qYnJDKHuzicTCv6Q3nDPdkF8En0AJsxLwuHC8E9g2gP5cD2QdJxgIF59G58Qjmzpftc         47m/QJ6iEeFnuUPDoVvuWLj5QgOslYPlXmHnOY9dyA0st6k+XhqUAFvbMKPOn8x4apOI         qoZBvAwVBDlMsM+LWgB/Tj8qQN+dVf/3w/fq47/8n3rdmhq9WKqD5VSZjKWlxm8YzWns         PyTQ==
X-OlkEid: 00000000D07AAE8E23CDBE4CA04D01CCD82FCB7E070034AD76187591974DBF6C4F76951C873A01000200000000005797C783AAECB34FA6C879FF487E64D90000000010D70000F859786ADA03954BB19A8B26959787F8
X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
        d=1e100.net; s=20260707; t=1790082773; x=1790687573;
        h=content-type:cc:to:subject:message-id:date:from:mime-version
         :x-gm-gg:x-gm-message-state:from:to:cc:subject:date:message-id
         :reply-to:content-type;
        bh=nCgFNcVZDZx5AYqGIhxQ65IP19KCUi03ox9yYl50gqk=;
        b=MD7bC8iCiRbRW5+cTueYSMA4nssYY1Lk8+iRuJ/2l+kYgkzqhVsazWtXrYUdLGy8vY
         oFrDVdf7CzKrgeCGe3A5ijQLkZguheK3LusIqzJykT6f6ClBx9u/L4+wSBMgfCCeinhx
         95uzCs7giU4M2xpUNIEZ0bOnHPNdewbsR/UbJQn0KIFJdax8O64mp5m0NBpwlI9jmHLT
         Vhh76sYPExvAdiZsPFBcRtPts8DmFf+G8lKE2L3FEpv4FhivdmQzg8rFLEqxZQ6a+bVk
         mgaNOMko538ZzDSzv1O183j50AkMClvHgAwxePm0iyCzldJUXGHKWTVwoSXa1288LXOp
         CQdg==
X-Gm-Message-State: AFuF++kqFLeu3Ov+sg7cL1j+i1z6THz+2aOT3tjP8Y73Q2CEjFiXZBA7
	KLC2hV3ZQFEmXGak2wetYLbPX4WsIfxbewZ1dKnmps/8rDYo+cfpr1Q25nlp4t9FwM5zIz5Otva
	BPh6ZCYYmWNTlX2yHu3iBLHDptW3NGhklKuyj
X-Gm-Gg: AYBFou0/i/rdY6nmbvLJywa9mo2R5cHNCAcaUNmJWvIz21m+11/82M28NDOPed9rdvM
	BajCE9cS9wcZuJwM8S/A6447TOP11oSjVcwdrxa6Ps2LqrJ2Zh8Lxx75ADtWjAoAkaVl5mJL+o/
	4mO9lFnCy1yTM2/oKbYxNhdOBj8qpiCXunZ4Xa2S2QK3wYGZTSteVf75W8PNFeicFgsKfb4dz7b
	/Dj9Vwh8wyXubrzs1ibwzciiVioRet4PJ/Y/MvgUNsRqVdSEOlm41jhTOeSavVWpID7j5kB86hz
	N709kxVzmIumpLj2KFmRFGydzM4qJymVfiMrnV+ZLQtbgZafm5m8UU4gOhZc6GjzHzkX/4Mzbre
	cBYuWFIgNTgc3JE+p7GmotzqAxDViwR3Qi1eQP41wd9dk
X-Received: by 2002:a2e:bc02:0:b0:39c:7d57:a3ae with SMTP id
 38308e7fff4ca-3a5fbbb3712mr28850421fa.0.1790082773312; Tue, 22 Sep 2026
 06:12:53 -0700 (PDT)
X-Gm-Features: AcwNN1W9p3L25Ps_4-L3OQ0R2xjd6TqArKEJIj3ps-JCqn7fAcPrwo6CvqDgpns

This is a multipart message in MIME format.

------=_NextPart_000_00C5_01DD4B6A.BB543EE0
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: 8bit


Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.

Dear Minister Karmen Joller,

On behalf of the Latvian Cystic fibrosis society, I have the honour to 
invite you to participate in the opening of the VI International Conference 
“Cystic Fibrosis in the Baltic Countries and Europe”, which will take place 
on 13 November 2026 in the “Lielupe” meeting room at the Radisson Blu Hotel 
Daugava, Kuģu iela 24, Riga, Latvia.

The conference is organized by the patient organization Latvian Cystic 
fibrosis society and will bring together cystic fibrosis specialists, 
healthcare professionals, researchers and representatives of patient 
organizations from Latvia, Lithuania, Estonia and other European countries. 
Many healthcare professionals will participate in the conference, and 
attendees will receive certificates with continuing medical education (CME) 
points, as this is an international scientific conference.

This year, particular attention will be devoted to the development of adult 
cystic fibrosis care, multidisciplinary cooperation, the development of 
specialized CF centres, access to modern treatment and the exchange of 
experience between European countries. The cystic fibrosis patient 
organizations in Latvia, Lithuania and Estonia have had a friendly and close 
cooperation for many years. The cooperation between the three Baltic 
countries is especially important to us – we regularly share our experience 
and support each other. We highly value the support of each Baltic country 
in ensuring access to innovative medicines for people with cystic fibrosis, 
thereby providing patients with the opportunity to receive modern treatment.

Therefore, during the opening of the conference, we would like to give the 
floor to the Ministers of Health of Latvia, Lithuania and Estonia, or their 
designated representatives, to address the conference participants with a 
welcome speech. It would be a great honour for us if you could represent 
Estonia at the opening of the conference and address the conference 
participants.Your participation would be an important expression of the 
cooperation between the Baltic countries and their support for the further 
development of healthcare and improvement of the quality of life of people 
living with cystic fibrosis.

We sincerely hope that you will be able to join us in Riga.

Please let us know whether you or your designated representative will be 
able to participate in the opening of the conference.

About the LCFB

The Latvian Cystic Fibrosis Association (LCFB) is a member of CF Europe, the 
federation of national cystic fibrosis patient organizations in Europe, 
representing people living with cystic fibrosis (CF) and their families in 
more than 39 countries across Europe. 
https://www.cf-europe.eu/who-we-are/#cfe-members


Kind regards,
Alla Belinska

Latvian Cystic fibrosis society chairwoman
Phone number: +371 29161629
Web:  <http://www.cistiskafibroze.lv> www.cistiskafibroze.lv
Adress: Kalku street 1, Viesite, Jekabpils county, Latvia, LV-5237




------=_NextPart_000_00C5_01DD4B6A.BB543EE0
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<html><head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; =
charset=3Dutf-8">
</head>
<body>
<table class=3D"MsoNormalTable" border=3D"0" cellspacing=3D"0" =
cellpadding=3D"0" align=3D"left" width=3D"100%" =
style=3D"width:100.0%;mso-cellspacing:0cm;mso-yfti-tbllook:1184; =
mso-table-lspace:2.25pt;mso-table-rspace:2.25pt;mso-table-anchor-vertical=
:paragraph;mso-table-anchor-horizontal:column;mso-table-left:left;mso-pad=
ding-alt:0cm 0cm 0cm 0cm">
<tbody>
<tr =
style=3D"mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes">
<td style=3D"background:#910A19;padding:5.25pt 1.5pt 5.25pt 1.5pt"></td>
<td width=3D"100%" =
style=3D"width:100.0%;background:#FDF2F4;padding:5.25pt 3.75pt 5.25pt =
11.25pt; word-wrap:break-word" cellpadding=3D"7px 5px 7px 15px" =
color=3D"#212121">
<div>
<p class=3D"MsoNormal" =
style=3D"mso-element:frame;mso-element-frame-hspace:2.25pt; =
mso-element-wrap:around;mso-element-anchor-vertical:paragraph;mso-element=
-anchor-horizontal: column;mso-height-rule:exactly">
<span style=3D"font-size:9.0pt;font-family: &quot;Segoe =
UI&quot;,sans-serif;mso-fareast-font-family:&quot;Times New =
Roman&quot;;color:#212121"><strong>T=C3=A4helepanu!
</strong>Tegemist on v=C3=A4lisv=C3=B5rgust saabunud kirjaga.<br>
Tundmatu saatja korral palume linke ja faile mitte =
avada.<o:p></o:p></span></p>
</div>
</td>
</tr>
</tbody>
</table>
<div>
<div dir=3D"ltr">
<div>Dear Minister Karmen Joller,&nbsp;&nbsp;</div>
<div><br>
</div>
<div>
<div dir=3D"ltr" class=3D"gmail_signature" =
data-smartmail=3D"gmail_signature">
<div dir=3D"ltr">
<div>
<div><span style=3D"background-color:transparent">On behalf of the =
Latvian Cystic fibrosis society, I have the honour to invite you to =
participate in the opening of the VI International Conference =
=E2=80=9CCystic Fibrosis in the Baltic Countries and Europe=E2=80=9D, =
which will
 take place on 13 November 2026 in the =E2=80=9CLielupe=E2=80=9D meeting =
room at the Radisson Blu Hotel Daugava, Ku=C4=A3u iela 24, Riga, =
Latvia.</span></div>
<div>
<p class=3D"gmail-isSelectedEnd">The conference is organized by the =
patient organization Latvian Cystic fibrosis society and will bring =
together cystic fibrosis specialists, healthcare professionals, =
researchers and representatives of patient organizations from
 Latvia, Lithuania, Estonia and other European countries. Many =
healthcare professionals will participate in the conference, and =
attendees will receive certificates with continuing medical education =
(CME) points, as this is an international scientific conference.</p>
<p class=3D"gmail-isSelectedEnd">This year, particular attention will be =
devoted to the development of adult cystic fibrosis care, =
multidisciplinary cooperation, the development of specialized CF =
centres, access to modern treatment and the exchange of experience
 between European countries. The cystic fibrosis patient organizations =
in Latvia, Lithuania and Estonia have had a friendly and close =
cooperation for many years. The cooperation between the three Baltic =
countries is especially important to us =E2=80=93 we regularly
 share our experience and support each other. We highly value the =
support of each Baltic country in ensuring access to innovative =
medicines for people with cystic fibrosis, thereby providing patients =
with the opportunity to receive modern treatment.</p>
<p class=3D"gmail-isSelectedEnd">Therefore, during the opening of the =
conference, we would like to give the floor to the Ministers of Health =
of Latvia, Lithuania and Estonia, or their designated representatives, =
to address the conference participants with a welcome
 speech.&nbsp;<span style=3D"background-color:transparent">It would be a =
great honour for us if you could represent Estonia at the opening of the =
conference and address the conference participants.</span><span =
style=3D"background-color:transparent">Your participation
 would be an important expression of the cooperation between the Baltic =
countries and their support for the further development of healthcare =
and improvement of the quality of life of people living with cystic =
fibrosis.</span></p>
<p class=3D"gmail-isSelectedEnd">We sincerely hope that you will be able =
to join us in Riga.</p>
<p class=3D"gmail-isSelectedEnd">Please let us know whether you or your =
designated representative will be able to participate in the opening of =
the conference.</p>
<p class=3D"gmail-isSelectedEnd"><u =
style=3D"background-color:transparent">About the LCFB</u></p>
<p class=3D"gmail-isSelectedEnd"><span =
style=3D"background-color:transparent">The Latvian Cystic Fibrosis =
Association (LCFB) is a member of CF Europe, the federation of national =
cystic fibrosis patient organizations in Europe, representing people =
living with cystic
 fibrosis (CF) and their families in more than 39 countries across =
Europe.&nbsp;</span><a =
href=3D"https://www.cf-europe.eu/who-we-are/#cfe-members" =
target=3D"_blank" =
style=3D"background-color:transparent;color:rgb(5,99,193);font-family:&qu=
ot;Times New =
Roman&quot;,serif;font-size:12pt">https://www.cf-europe.eu/who-we-are/#cf=
e-members</a></p>
</div>
<div><br>
</div>
</div>
<div><i style=3D"background-color:transparent"><font face=3D"verdana, =
sans-serif">Kind regards,</font></i></div>
<div><i><font face=3D"verdana, sans-serif"><b>Alla =
Belinska</b></font></i><br>
</div>
<div><i><font face=3D"verdana, sans-serif"><b>Latvian Cystic fibrosis =
society chairwoman</b></font></i></div>
<div><i><font face=3D"verdana, sans-serif">Phone number: +371 =
29161629</font></i></div>
<div><i><font face=3D"verdana, sans-serif">Web:&nbsp;<a =
href=3D"http://www.cistiskafibroze.lv" =
target=3D"_blank"><b>www.cistiskafibroze.lv</b></a><br>
<span style=3D"color:rgb(34,34,34)">Adress: Kalku street 1, Viesite, =
Jekabpils county, Latvia, LV-5237</span></font></i></div>
<div><br>
</div>
<div><i><b><br>
</b></i></div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>

------=_NextPart_000_00C5_01DD4B6A.BB543EE0--
